SearchDictionaryMobileLogin

Immunologic and structural analysis of eight novel domain-deletion beta3 integrin peptides designed for detection of HPA-1 antibodies.

AbstractBACKGROUND: The single-nucleotide polymorphism (SNP) rs5918 in the ITGB3 gene defines the human platelet antigen-1 (HPA-1) system encoding a Leu (HPA-1a) or Pro (HPA-1b) at position 33. HPA-1 antibodies are clinically the most relevant in the Caucasoid population, but detection currently requires alpha(IIb)beta3 integrin from the platelets of HPA-genotyped donors. OBJECTIVES: We set out to define the beta3 integrin domains required for HPA-1a antibody binding and produce recombinant soluble beta3 peptides for HPA-1 antibody detection. METHODS: We designed two sets (1a and 1b) of four soluble beta3 domain-deletion peptides (deltaSDL, deltabetaA, PSIHybrid, PSI), informed by crystallography studies and computer modeling. The footprints of three human HPA-1a-specific phage antibodies were defined by analyzing binding patterns to the beta3 peptides and canine platelets, and models of antibody-antigen interfaces were derived. Specificity and sensitivity for HPA-1a detection were assessed using sera from 140 cases of fetomaternal alloimmune thrombocytopenia (FMAIT). RESULTS: Fusion of recombinant proteins to calmodulin resulted in high-level expression in Drosophila S2 cells of all eight beta3 peptides. Testing of FMAIT samples indicated that deltabetaA-Leu33 is the superior peptide for HPA-1a antibody detection, with 96% sensitivity and 95% specificity. The existence of type I and II categories of HPA-1a antibodies was confirmed by the study of HPA-1a phage antibody footprints and the reactivity pattern of clinical samples with the four beta3-Leu33 peptides, but there was no correlation between antibody category and clinical severity of FMAIT. CONCLUSIONS: Soluble recombinant beta3 peptides can be used for detection of clinical HPA-1a antibodies.
AuthorsP Stafford, C Ghevaert, K Campbell, C Proulx, G Smith, L M Williamson, E Ranasinghe, N A Watkins, J A Huntington, W H Ouwehand (Affiliation: Department of Haematology, University of Cambridge, Cambridge, UK.)
JournalJournal of thrombosis and haemostasis : JTH (J Thromb Haemost) Vol. 6 Issue 2 Pg. 366-75 (Feb 2008) ISSN: 1538-7836 England
PMID18045240 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • 1a alloantigen, human
  • Antigens, Human Platelet
  • Epitopes
  • Integrin beta3
  • Isoantibodies
  • Platelet Glycoprotein GPIIb-IIIa Complex
  • Recombinant Fusion Proteins
Topics
  • Animals
  • Antigen-Antibody Reactions
  • Antigens, Human Platelet (chemistry, genetics, immunology)
  • Blood Platelets (metabolism)
  • Dogs
  • Enzyme-Linked Immunosorbent Assay
  • Epitopes (chemistry, immunology)
  • Female
  • Humans
  • Infant, Newborn
  • Integrin beta3 (chemistry, genetics, immunology)
  • Intracranial Hemorrhages (etiology, immunology)
  • Isoantibodies (blood, chemistry, immunology)
  • Models, Molecular
  • Platelet Glycoprotein GPIIb-IIIa Complex (chemistry, immunology)
  • Polymorphism, Single Nucleotide
  • Pregnancy
  • Protein Binding
  • Protein Conformation
  • Protein Interaction Mapping
  • Protein Structure, Tertiary
  • Recombinant Fusion Proteins (immunology)
  • Sequence Deletion
  • Thrombocytopenia, Neonatal Alloimmune (diagnosis, immunology)